The area under the ROC curve of MATK was 0.743, which was not significantly different from the final regression model 0.803, suggesting that MATK can be used as a biomarker for diagnosis of WMH, indicating that MATK can provide help in the diagnosis accuracy of CCH. Here, MATK is linked to columnar cell hyperplasia of the breast.